Tag: clinical
ABIONYX Pharma selected as Late-Breaking Clinical Results Poster Presentation during “Kidney Week” of the 2023 Annual Meeting of the American Society of Nephrology (ASN) for clinical data from the RACERS phase 2 study in sepsis – 16/10/2023 at 07:00
• The “Late-Breaking Clinical Results” session will present a world premiere of clinical data from the RACERS study in sepsis having achieved the primary and secondary objective of the study…
“It is urgent to invent new solutions adapted to their clinical and educational specificity”
DIn a class of twenty-eight children, it is estimated that on average, at least two students are affected by learning disorders, also called “dys disorders” because they include dyslexia, dyspraxia,…
PHAXIAM Therapeutics announces a high level of performance of its two anti-Staphylococcus aureus phages on clinical strains – 10/09/2023 at 10:05 p.m.
Data obtained from the phagogram developed by PHAXIAM, the first phage sensitivity test with CE marking, showed a response rate of 98% on 105 clinical strains of S. aureus. Lyon…
PHAXIAM Therapeutics announces a high level of performance of its two anti-Staphylococcus aureus phages on clinical strains – 10/09/2023 at 10:05 p.m.
PHAXIAM Therapeutics announces a high level of performance of its two anti- Staphylococcus aureus on clinical strains Data obtained from the phagogram developed by PHAXIAM, the first phage sensitivity test…
Phaxiam Therapeutics: high level of performance of both phages against clinical bacterial strains
By Alexandra Saintpierre Published on 09/10/2023 at 10:38 p.m. Photo credit © ChaunuPictures (Boursier.com) — Phaxiam Therapeutics announces…
Eli Lilly: several clinical results presented at the end of October in Madrid – 06/10/2023 at 2:22 p.m.
(AOF) – Eli Lilly and Company is expected to rise in the pre-market on Wall Street after announcing today that data from studies on its products Verzenio, Retevmo and imlunestrant…
Abivax highlights its clinical development program for obefazimod in ulcerative colitis
By Claude Leguilloux Published on 02/10/2023 at 6:49 p.m. Photo credit © Abivax (Boursier.com) — Abivax SA, a…
NFL BIOSCIENCES: PROMISING RESULTS OF THE PRECESTO CLINICAL STUDY REVEALING A LONG-LASTING EFFECT OF NFL-101 AND MODIFICATION OF THE COMMUNICATION STRATEGY OF THE RESULTS OF THE CESTO II STUDY – 09/25/2023 at 08:00
The PRECESTO clinical trial shows a clinically relevant reduction in smoking satisfaction in smokers not trying to quit with a more lasting effect than expected. The therapeutic potential of NFL-101…
Affluent Medical: positive clinical results for the Kalios mitral ring
(AOF) – Affluent Medical announced positive clinical results from a pivotal study with its Kalios mitral ring. The medtech specialist in cardiology specifies that this ring for repairing the mitral…
Affluent Medical: positive clinical results for the Kalios mitral ring – 09/13/2023 at 6:06 p.m.
(AOF) – Affluent Medical announced positive clinical results from a pivotal study with its Kalios mitral ring. The medtech specialist in cardiology specifies that this ring for repairing the mitral…
Affluent Medical Announces Positive Clinical Results and Key Data to Optimize Its Structural Cardiology Strategy
By Hector Chaunu Published on 09/13/2023 at 6:39 p.m. Photo credit © ChaunuPictures (Boursier.com) — Affluent Medicala French…
Biophytis: The United States authorizes Biophytis to launch a final phase of clinical trials in sarcopenia
(BFM Bourse) – The biopharmaceutical company has obtained the green light from the FDA to launch its phase III study SARA-31 for its potential treatment against sarcopenia. Biophytis obtained similar…